KK

Kaushal Kumar Pandit

Active Director Director DIN 10085077
DIN 10085077 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kaushal Kumar Pandit

Data last updated:

Kaushal Kumar Pandit is a Director at Serov Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10085077
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20232023Active

Board colleagues of Kaushal Kumar Pandit

Directorship timeline

Open interactive timeline →
Serov Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kaushal Kumar Pandit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaushal Kumar Pandit

Kaushal Kumar Pandit currently holds 1 directorship: Serov Pharmaceuticals Private Limited (Director, since 23 Mar 2023).

Kaushal Kumar Pandit was first appointed on 23 Mar 2023 as Director at Serov Pharmaceuticals Private Limited.

The current boards of Kaushal Kumar Pandit's companies include Mukul Kumar Mishra (Serov Pharmaceuticals Private Limited), Somesh Bhardwaj (Serov Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available